Benazepril ve hidroklorotiyazid ve Enalaprilat etkileşimi
Benazepril ve hidroklorotiyazid ve Enalaprilat: her iki reçeteleme etiketi de bu kombinasyonu kontrendikasyon, kutulu uyarı veya kaçınma talimatı gibi en güçlü ifadelerle işaretliyor.
Reçeteyi yazan hekimin yönlendirmesi olmadan birlikte kullanmayın. Aşağıdaki etiket ifadeleri, FDA'nın kullandığı en güçlü ifadelerdir.
FDA etiketleri ne diyor
Kaynak: Benazepril ve hidroklorotiyazid (Lotensin HCT) etiketi · yürürlük tarihi 2026-02-24
Lotensin HCT is also contraindicated in patients who are hypersensitive to benazepril, to any other ACE inhibitor, to hydrochlorothiazide, or to other sulfonamide-derived drugs.
Like other ACE inhibitors, benazepril has been only rarely associated with hypotension in uncomplicated hypertensive patients.
The thiazide component of Lotensin HCT may potentiate the action of other antihypertensive drugs, especially ganglionic or peripheral adrenergic-blocking drugs.
Other ACE inhibitors have had less than additive effects with beta-adrenergic blockers, presumably because drugs of both classes lower blood pressure by inhibiting parts of the renin-angiotensin system.
Lotensin HCT should be used cautiously in patients receiving concomitant therapy with other antihypertensives.
Kaynak: Enalaprilat etiketi · yürürlük tarihi 2024-01-04
…sometimes associated with oliguria and/or progressive azotemia, and rarely with acute renal failure and/or death, include those with the following conditions or characteristics: heart failure, hyponatremia, high dose diuretic therapy, recent intensive diuresis or increase in diuretic dose, renal dialysis, or severe volume and/or salt depletion of any etiology.
WARNINGS Hypotension Excessive hypotension is rare in uncomplicated hypertensive patients but is a possible consequence of the use of enalaprilat especially in severely salt/volume depleted persons such as those treated vigorously with diuretics or patients on dialysis.
It may be advisable to eliminate the diuretic, reduce the diuretic dose or increase salt intake cautiously before initiating therapy with Enalaprilat Injection in patients at risk for excessive hypotension who are able to tolerate such adjustments (see PRECAUTIONS, Drug Interactions ; ADVERSE REACTIONS, and DOSAGE AND ADMINISTRATION ).
Because of the potential for an excessive fall in blood pressure especially in these patients, therapy should be followed closely whenever the dose of enalaprilat is adjusted and/or diuretic is increased.
Drug Interactions Hypotension - Patients on diuretic therapy Patients on diuretics and especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with enalaprilat.
Bu ikisinden fazlasını mı kullanıyorsunuz? Etkileşimler üst üste biner. Tüm listenizi tek seferde kontrol edin; liste tarayıcınızda kalır.
Sorgulama aracında açTıbbi tavsiye değildir. Interaction Checker, FDA etiket metinlerini ve NIH bilgi sayfalarını alıntılar. Bir etkileşimin sizin için önemli olup olmadığı dozlara, zamanlamaya, böbrek ve karaciğer fonksiyonuna ve diğer sağlık durumlarına bağlıdır. Bir eczacıya veya reçeteyi yazan hekime danışarak doğrulayın.